Recent events
Recent events tied to this brand in public sources.
Back to profile5 entries
2021
China approves LY03015 clinical trial
China's Center for Drug Evaluation approved Green Valley Pharmaceutical's investigational drug LY03015 for clinical trials.
2020
Luye Pharma releases 2019 annual results
Luye Pharma Group released its 2019 annual results, reporting sales revenue of RMB 6.358 billion, up 22.9% year over year.
2019
GreenLeaf Pharmaceutical announced acquisition of Boan Biotech
GreenLeaf Pharmaceutical announced that it would acquire Shandong Boan Biotechnology Co., with the transaction priced at 1.447 billion yuan and paid in installments under the agreement.
2019
Luye Pharma announces acquisition of Boan Biotech
Luye Pharma announced that it would acquire Shandong Boan Biotechnology, including Boan's products under development, antibody-screening platform, intellectual property and antibody-production platform. The transaction was to be paid in installments.
2019
Green Leaf announces acquisition of 98% of Shandong Boan
Green Leaf Pharmaceutical announced that its wholly owned subsidiary would acquire a 98% stake in Shandong Boan Biotechnology from Green Leaf Investment Group for a total purchase price of up to RMB 1.4467 billion.